Amyris, Inc. (AMRS)


Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Amyris, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Amyris, Inc. (“Amyris” or the “Company”) (NASDAQ:AMRS) of the June 3, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

If you invested in Amyris stock or options between March 15, 2018 and March 19, 2019 and would like to discuss your legal rights, please fill out the form below.  There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com. 

CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn:  Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

The lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of all those who purchased Amyris securities between March 15, 2018 and March 19, 2019 (the “Class Period”).  The case, Mulderrig et al v. Amyris, Inc. et al, No. 19-cv-01765 was filed on April 3, 2019, and has been assigned to Judge Yvonne Gonzalez Rogers.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose: (1) that the company lacked sufficient resources to accurately account for certain transactions; (2) that, as a result, there was a material weakness in the company's internal controls over financial reporting; (3) that, as a result, the company would be unable to timely file its annual report; and (4) that, as a result of the foregoing, defendants' positive statements about the company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

On November 13, 2018 when the Company reported poor financial results, which it attributed to the “volatility of the Vitamin E market.”

On this news, the Company's stock price fell from $5.90 per share on November 13, 2019 to $4.14 per share on November 14, 2019--a $1.76 or 29.83% drop.

Then, on March 19, 2019, after the market closed, the Company filed a Notification of Late Filing on Form 12b-25 with the Securities and Exchange Commission (“SEC”).

On this news, the Company’s stock price fell from $3.88 per share on March 19, 2019 to $3.10 per share on March 20, 2019—a $0.78 or 20.10% drop.

Contact us

Amyris, Inc. (AMRS)

Loading captcha, please wait...

* The submission of this form does not create an attorney-client relationship.

Details

Filed on 04/11/2019

Ticker AMRS

Office

685 Third Avenue 26th Floor

10017 New York, New York

Phone (212) 983-9330

Fax (212) 983-9331

Counsel

Richard W. Gonnello rgonnello@faruqilaw.com Phone (212) 983-9330 Fax (212) 983-9331

Finding us

Our Offices


Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331

California

10866 Wilshire Boulevard Suite 1470
Los Angeles, California 90024
(424) 256-2884
(424) 256-2885

Delaware

3828 Kennett Pike Suite 201
Wilmington, Delaware 19807
(302) 482-3182
(302) 482-3612

Georgia

3975 Roswell Rd Suite A
Atlanta, Georgia 30342
(404) 847-0617
(404) 506-9534

Pennsylvania

1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Wilmington, Delaware

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania